MiMedx Group, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
MDXG Nasdaq 2836 www.mimedx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for MiMedx Group, Inc.

MIMEDX Enters into Exclusive U.S. Distribution Agreement for RegenKit®-Wound Gel - Dec 22nd, 2025 7:43 am
With 47% stake, MiMedx Group, Inc. (NASDAQ:MDXG) seems to have captured institutional investors' interest - Dec 20th, 2025 5:57 am
MIMEDX Announces Publication in the Journal of Inflammation Focused on Immunomodulatory Effects of Purion® Processed Human Amniotic Membrane Allografts In Vitro - Dec 19th, 2025 7:00 am
MiMedx Group (MDXG) Is Down 8.4% After EPIEFFECT’s Strong Interim Trial Data Outshines Standard Care - Nov 22nd, 2025 11:09 pm
Wound Care Market Report 2025: Global Market to Surpass $30 Billion by 2029, Driven by Advancements in Wound Care Technologies, Increasing Elderly Populations, and Rising Chronic Conditions - Nov 21st, 2025 3:54 am
MiMedx (MDXG) Just Flashed Golden Cross Signal: Do You Buy? - Nov 17th, 2025 7:55 am
MIMEDX Provides Update on EPIEFFECT® Randomized Controlled Trial - Nov 13th, 2025 6:00 am
MIMEDX to Participate in Upcoming Investor Conferences - Nov 10th, 2025 2:01 pm
Exploring 3 High Growth Tech Stocks in the US Market - Nov 7th, 2025 4:38 am
MIMEDX Comments on CY 2026 Medicare Physician Fee Schedule Final Rule - Nov 3rd, 2025 7:15 am
Wall Street Analysts Predict a 64.86% Upside in MiMedx (MDXG): Here's What You Should Know - Oct 31st, 2025 7:55 am
Assessing MiMedx Group (MDXG) Valuation as Shares Show Renewed Momentum - Oct 31st, 2025 12:11 am
MiMedx Group (MDXG): Margin Decline Challenges Bullish Narratives Despite Strong Earnings Growth - Oct 30th, 2025 7:21 pm
MiMedx: Q3 Earnings Snapshot - Oct 29th, 2025 2:23 pm
MIMEDX Announces Record Revenue for Third Quarter 2025 - Oct 29th, 2025 2:01 pm
MIMEDX to Host Third Quarter 2025 Operating and Financial Results Conference Call on October 29 - Oct 15th, 2025 6:00 am
MIMEDX Announces Launch of EPIXPRESS® - Oct 6th, 2025 7:28 am
MiMedx Group, Inc.'s (NASDAQ:MDXG) Stock's On An Uptrend: Are Strong Financials Guiding The Market? - Sep 28th, 2025 6:21 am
MIMEDX to Sponsor and Attend Symposium on Advanced Wound Care (SAWC) Fall - Sep 3rd, 2025 6:00 am
MiMedx Group, Inc. (MDXG) Partners with Vaporox for Advanced Wound Therapy - Aug 29th, 2025 3:11 am